Llwytho...
Sustained responses to lasmiditan: Results from post-hoc analyses of two Phase 3 randomized clinical trials for acute treatment of migraine
BACKGROUND: Sustained pain freedom is an important attribute of acute migraine therapies for patients and physicians. Here we report efficacy of the centrally penetrant, highly selective, 5-HT(1F) agonist lasmiditan on sustained pain freedom and other outcomes at 24 and 48 hours post-dose. STUDY DES...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Cephalalgia |
|---|---|
| Prif Awduron: | , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
SAGE Publications
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6791026/ https://ncbi.nlm.nih.gov/pubmed/31266353 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0333102419859313 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|